Cargando…

Radiovaccination Hypothesis

The details of patients who have entered remission from metastatic melanoma following palliative radiotherapy are reported. We review the relevant immune physiology and radiotherapy particulars and propose the hypothesis that radiovaccination with high fractional dose to skin metastases can stimulat...

Descripción completa

Detalles Bibliográficos
Autor principal: Eapen, Libni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418027/
https://www.ncbi.nlm.nih.gov/pubmed/28480153
http://dx.doi.org/10.7759/cureus.1135
_version_ 1783234007311319040
author Eapen, Libni
author_facet Eapen, Libni
author_sort Eapen, Libni
collection PubMed
description The details of patients who have entered remission from metastatic melanoma following palliative radiotherapy are reported. We review the relevant immune physiology and radiotherapy particulars and propose the hypothesis that radiovaccination with high fractional dose to skin metastases can stimulate the development of a robust systemic anti-tumoral immune response capable of causing remission of metastatic disease.
format Online
Article
Text
id pubmed-5418027
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-54180272017-05-05 Radiovaccination Hypothesis Eapen, Libni Cureus Oncology The details of patients who have entered remission from metastatic melanoma following palliative radiotherapy are reported. We review the relevant immune physiology and radiotherapy particulars and propose the hypothesis that radiovaccination with high fractional dose to skin metastases can stimulate the development of a robust systemic anti-tumoral immune response capable of causing remission of metastatic disease. Cureus 2017-04-04 /pmc/articles/PMC5418027/ /pubmed/28480153 http://dx.doi.org/10.7759/cureus.1135 Text en Copyright © 2017, Eapen et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Oncology
Eapen, Libni
Radiovaccination Hypothesis
title Radiovaccination Hypothesis
title_full Radiovaccination Hypothesis
title_fullStr Radiovaccination Hypothesis
title_full_unstemmed Radiovaccination Hypothesis
title_short Radiovaccination Hypothesis
title_sort radiovaccination hypothesis
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418027/
https://www.ncbi.nlm.nih.gov/pubmed/28480153
http://dx.doi.org/10.7759/cureus.1135
work_keys_str_mv AT eapenlibni radiovaccinationhypothesis